BF
PTCT icon

BOK Financial’s PTC Therapeutics PTCT Stock Holding History

BOK Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16
Closed -$781 – 1185
2025
Q2 		$781 Hold
16
– – ﹤0.01% 1096
2025
Q1 		$815 Hold
16
– – ﹤0.01% 1194
2024
Q4 		$703 Buy
+16
New +$685 ﹤0.01% 1224
2023
Q1 		– Sell
-10,887
Closed -$416K – 1233
2022
Q4 		$416K Buy
+10,887
New +$453K 0.01% 711

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BOK Financial's PTCT Position: Q3 2025 in Review

BOK Financial sold out of PTC Therapeutics (PTCT) in Q3 2025, closing a stake of 16 shares — an estimated $781 sold.

BOK Financial first reported a position in PTCT in Q4 2022 and held it in 4 quarters. The position peaked at $416K in Q4 2022. 293 funds tracked by Wall St. Rank hold PTCT as of Q3 2025.

  • BOK Financial reported no remaining PTC Therapeutics position as of Q3 2025 after selling out during the quarter.
  • BOK Financial sold 16 PTC Therapeutics shares in Q3 2025, an estimated $781.
  • BOK Financial first reported a position in PTC Therapeutics in Q4 2022 and held it in 4 quarters.
  • BOK Financial's PTC Therapeutics position peaked at $416K in Q4 2022.
  • 293 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2025.

Based on BOK Financial's 13F filing for Q3 2025, filed 13 Nov 2025.